Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease

• Main Authors: David Y. Graham (Author), Saleh A. Naser (Author), Thomas Borody (Author), Zbigniew Hebzda (Author), Harry Sarles (Author), Scott Levenson (Author), Robert Hardi (Author), Tomasz Arłukowicz (Author), Petar Svorcan (Author), Reza Fathi (Author), Aida Bibliowicz (Author), Patricia Anderson (Author), Patrick McLean (Author), Clara Fehrmann (Author), M. Scott Harris (Author), Shuhong Zhao (Author), Ira N. Kalfus (Author)
• Format: Book
• Published: MDPI AG, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This study, conducted between 4 October 2013, and 30 November 2018, tested the hypothesis that triple antimicrobial therapy, targeting <i>Mycobacterium avium</i> subspecies <i>paratuberculosis</i> (MAP), long considered a putative cause, would favorably affect Crohn's di...